Investors, Partners & Licensing

 

Treovir is actively seeking partners and investors to support the development and commercialization of G207 in the US and globally.  

​

Investors and Partners should share Treovir's vision for bringing a potentially life-saving therapy to pediatric patients with minimal barriers to access and at fair pricing.